Publications:

Targeting TKI-Activated NFKB2-MIF/CXCLs-CXCR2 Signaling Pathways in FLT3 Mutated Acute Myeloid Leukemia Reduced Blast Viability.

Biomedicines

Cao, Huynh H; Tadros, Verena V; Hiramoto, Benjamin B; Leeper, Kevin K; Hino, Christopher C; Xiao, Jeffrey J; Pham, Bryan B; Kim, Do Hyun DH; Reeves, Mark E ME; Chen, Chien-Shing CS; Zhong, Jiang F JF; Zhang, Ke K KK; Xie, Linglin L; Wasnik, Samiksha S; Baylink, David J DJ; Xu, Yi Y

Publication Date: 2022-04-30

Variant appearance in text: DNMT3A: 284_307del

PubMed Link: 35625776

Variant Present in the following documents:

• biomedicines-10-01038.pdf

View BVdb publication page

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.

Oncotarget

Hou, Hsin-An HA; Liu, Chieh-Yu CY; Kuo, Yuan-Yeh YY; Chou, Wen-Chien WC; Tsai, Cheng-Hong CH; Lin, Chien-Chin CC; Lin, Liang-In LI; Tseng, Mei-Hsuan MH; Chiang, Ying-Chieh YC; Liu, Ming-Chih MC; Liu, Chia-Wen CW; Tang, Jih-Luh JL; Yao, Ming M; Li, Chi-Cheng CC; Huang, Shang-Yi SY; Ko, Bor-Sheng BS; Hsu, Szu-Chun SC; Chen, Chien-Yuan CY; Lin, Chien-Ting CT; Wu, Shang-Ju SJ; Tsay, Woei W; Tien, Hwei-Fang HF

Publication Date: 2016-02-23

Variant appearance in text: DNMT3A: 284_307del

PubMed Link: 26812887

Variant Present in the following documents:

• Main text

View BVdb publication page